remission

Cutting-edge Cancer Treatment Achieves 50% Remission Rate, Outperforming Conventional Methods: Meet Dr. Philip Salem

by
Cutting-edge Cancer Treatment Achieves 50% Remission Rate, Outperforming Conventional Methods: Meet Dr. Philip Salem

Breakthrough Cancer Treatment Achieves 50% Remission Rate: Meet the Doctor Behind It Breakthrough Cancer Treatment Achieves 50% Remission Rate: Meet the Doctor Behind It Published on August 15, 2022 The Groundbreaking Treatment Cancer patients have flocked from all over the world to a Houston oncologist, Philip Salem, who developed a cutting-edge treatment that sees 50 … Read more

Breast Cancer Survivor Takes on New York Marathon as a Snub to Cancer

by
Breast Cancer Survivor Takes on New York Marathon as a Snub to Cancer

It’s a real challenge, a “thumb” to cancer, that Florence Guelennoc has taken on. This 51-year-old from Quimper was diagnosed with breast cancer in December 2022. After 33 radiotherapy sessions, she will realize her dream: participating in the New York marathon this Sunday, November 5. A hell of a challenge that she will take on, … Read more

175,510 Convicts Receive Remissions on Indonesia’s Independence Day

by
175,510 Convicts Receive Remissions on Indonesia’s Independence Day

Jakarta – The moment of commemoration of the independence of the Republic of Indonesia was greeted with great enthusiasm. At this moment, convicts held in correctional institutions often receive remissions or reductions in their prison terms. in the moment HUT ke-78RI there are 175,510 prisoners who receive remission. As many as 2,606 of them even … Read more

Opportunity for Remission in Death Penalty Case for Ferdy Sambo

by

TEMPO.CO, Jakarta – Criminal law observer Boris Tampubolon said the cassation decision annulled the death penalty Freddy Sambo become life imprisonment open the opportunity to get rights remission or deductions from prison time that cannot be obtained if the sentence remains dead. “This is regulated in Article 10 of Law no. 22 of 2022 concerning … Read more

Frexalimab Shows Strikingly Positive Results in Treatment of Relapsing Multiple Sclerosis

by

Frexalimab, a second-generation anti-CD40L antibody, has shown “strikingly positive” effects in treating relapsing multiple sclerosis (MS), significantly reducing disease activity without depleting B cells. The drug is a novel, second-generation monoclonal antibody designed to block the costimulatory CD40/CD40L cellular pathway, the mechanism of which is believed to potentially modify T-and B-cell activation and innate immune … Read more